Latest Breaking News On - Chiesi group - Page 7 : comparemela.com
Pratteln, Switzerland, December 7, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces the promotion of Geert Jan van Daal, MD, PhD, to Chief Commercial Officer (CCO) and of Marc Schrader to Chief Technology Officer (CTO). Both will join the six-member Executive Committee effective January 1, 2024. “Santhera is transitioning to the commercial phase and will make AGAMREE® (vamorolone) available to patients in Europe starting in Germany in early 2024, subject to approval by the European Commissi
SpainSwitzerlandGermanyUnited-kingdomFranceUnited-statesItalyRotterdamZuid-hollandNetherlandsPrattelnSwitzerland-general